Share on

Global Polymerase Chain Reaction Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – By Type, Application & Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 1987
Pages: 175
Formats: report pdf report excel report power bi report ppt

Polymerase Chain Reaction Market Size (2022 to 2027)

The size of the global polymerase chain reaction market was valued at USD 8.3 billion in 2022. It is estimated to be growing at a CAGR of 6.60% to reach USD 11.43 billion by 2027.

The polymerase chain reaction is a process to duplicate or produce billion or millions of copies of a particular DNA/ genetic sample. This process helps scientists to collect a minute sample and produce billions of copies of genetic material. The molecular biology field utilizes this polymerase chain reaction more than any other field.

These polymerase chain reaction technologies are used to duplicate the millions of copies for a piece of deoxyribonucleic acid or any other genetic material. These technologies are more used to identify criminals and child identity in terms of the forensics department. These devices are also used to diagnose tuberculosis, AIDS, Lyme diseases, and middle ear infection. Also, in biotechnology and microbiology, and the academic field, these polymerase chain reaction technologies are used to identify microorganisms and their culture and cause diseases.

Polymerase chain reaction technologies are also used in genetic engineering, molecular biology, and research. In drug discovery and clinical diagnostics, polymerase chain reaction technologies play a significant role and help scientists in their studies. Polymerase chain reaction technologies also play a significant role in DNA sequencing and DNA cloning procedures.


Y-O-Y growth in the geriatric population, growing prevalence of infectious diseases, increased viral and other chronic infections with the highest spread ratio are forecasted to drive the global to polymerase chain reaction market growth.

According to the Centre for Disease Control and Prevention, around 5000 deaths are remarkably noted due to influenza infection registered in the United States, according to reports as of 2015. Even with the highest spread ratio, this rising number of infections and other diseases can be curbed by PCR techniques developments. Hence, this is an augmenting factor for market growth. An increase in the adoption of a polymerase chain reaction for various drug developments, disease identifications, and research applications is expected to boost the global polymerase chain reaction market growth.

Growing research developments, funding activities in gene therapy, and other genetics and biological fields also increase market size and revenue. Growing adoption of personalized medicines, personalized health check-ups, and various health benefits due to schemes are further expected to accelerate the global polymerize chain reaction market. An increase in awareness and acceptance of polymerase chain reaction technologies accelerates the growth rate of the market. 


The rise in non-validated tests and other fraud systems is expected to hamper the global polymerase chain reaction market.

Lack of reimbursement policies is also likely to inhibit the market growth for the polymerase chain reaction market. High costs associated with the setup, installation and maintenance of the equipment are expected to hinder the market's growth rate. A lot of skilled staff and workers are required to carry out this procedure. Hence the lack of professional staff and trained workers also negatively impacts market growth. Reduction in the number of polymerase chain reaction processes in various fields turns out a challenge for this market. 

Impact of covid-19 on the global polymerase chain reaction market:

The covid -19 cases have been increasing across the world. The disease's expansion through major countries has boosted demand for virus diagnostic tests in the suspicious population; this is mainly due to the scarcity or non-existence of rapid or specific diagnostic testing for these diseases. As a result of the significant applications of PCR in clinical diagnostics, the segment is expected to expand rapidly over the forecast period. In addition, the COVID-19 epidemic has accelerated the advancement of polymerase chain reaction science. Several types of studies are being carried out to prove the PCR test's accuracy. In March 2020, for example, researchers from the Center for Advanced Measurement Science collaborated with Chongqing University and the Wuhan and Beijing Centers for Disease Control and Prevention (CDC) to test the sensitivity of dPCR kits. In addition, two further experiments in China found that sensitivity was increased compared to the gold standard RT-qPCR. Bio-Rad Laboratories have produced a dPCR test for the identification of the SARS-CoV-2 virus in March 2020.




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Type, Application, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, APAC, Latin America, Middle East & Africa


This market research report on the global polymerase chain reaction market has been segmented and sub-segmented based on type, application, and region.

Polymerase Chain Reaction Market - By Type:

  • PCR consumables
  • PCR instruments

Based on the type, the consumables segment accounted for the largest market share of the polymerase chain reaction market in 2020 and more likely continue its growth throughout the forecast period. Significant demand for genetic testing and technologically sophisticated diagnostic tests in countries with unmet health needs is driving segment expansion. In addition, the introduction of new products is likely to lead to the segment's development. For example, Biocore Co. Ltd. released the first dPCR-based NIPT kits to diagnose chromosomal anomalies in March 2018.

Polymerase Chain Reaction Market - By Application:

  • DNA fingerprinting
  • DNA sequencing
  • DNA cloning
  • gene expression

Polymerase Chain Reaction Market - By Region:

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • The Middle East and Africa

Geographically, North America represented the largest share of the worldwide PCR market in 2019 took after by Europe. These two regions are relied upon to hold their position all through the forecast period. The North American area was among the first to support and implement the PCR-based applications to diagnose irresistible sicknesses, for example, HIV. Factors such as the establishment of new biotechnologies and pharmaceuticals, availability of equipment, and reagents necessary for carrying out this process, technological advancements, research and developments, and others drive market growth for the polymerase chain reaction market in North America.

The North American market growth is further driven by favorable government regulatory guidelines and reimbursement programs. The Department of Health and Human Services announced in February 2020 that the emergency use of diagnostics for COVID-19 diagnosis had been approved. The number of diagnostics products launched in the region improved as a result of this approval. In the regional market, the united states contributed the largest market share of polymerase chain reaction. The presence of advanced healthcare infrastructure and government initiatives are propelling market growth in the country. The Canadian polymerase chain reaction market is slightly contributing to regional market growth.

The European market is estimated to be the second-largest regional market in the global polymerase chain reaction market during the forecast period and likely to maintain its growth in the next 5 years. Growth healthcare expenditure and technological advancements in the healthcare sector are propelling the market growth in the region. The UK, Germany, France, Spain, and Italy are the major growth contributors in the region. over the years, the UK accounted for the largest market share of the polymerase chain reaction market and is forecasted to grow throughout the forecast period.

The Asia Pacific area is required to speak to the most elevated development rate during the forecast period. The Asia Pacific holds the largest shares due to its highest population growth. Other factors, such as increased chronic diseases, increased adoption of personalized medicines, increased awareness in early detection of diseases, and increased market value for this market in the Asia Pacific region.

Emerging countries like China, Japan, and India are significantly contributing to the APAC market, and the support is likely to maintain throughout the forecast period. In 2019, the Indian market had witnessed a stable growth rate that is estimated to continue during the forecast period.

MEA region expects slow growth due to lack of skilled staff, laboratories, and other industries, lack of awareness on biotechnologies and drug developments, high literacy rate.


Companies leading the global polymerase chain reaction market profiled in the report are Beckman Coulter, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, Harvard Bioscience, Maxim Biotech, Promega, and Siemens Healthcare.

Please wait. . . . Your request is being processed


How big is the global PCR market?

As per our research report, the global polymerase chain reaction (PCR) market size is expected to grow to USD 11.43 billion by 2027.

Which segment by type led the global PCR market in 2021?

Based on the type, the consumables segment dominated the global PCR market in 2021.

Which region led the global PCR market in 2021?

Geographically, the North American regional market dominated the polymerase chain reaction (PCR) market in 2021.

Which are the significant players operating in the global PCR market?

Beckman Coulter, Clontech Laboratories, Eppendorf, Fluidigm, PerkinElmer, bioMérieux, Harvard Bioscience, Maxim Biotech, Promega, and Siemens Healthcare are some of the notable companies operating in the global PCR market.

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample